Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impaired angiotensin II signaling in septic shock.
Picod A, Garcia B, Van Lier D, Pickkers P, Herpain A, Mebazaa A, Azibani F. Picod A, et al. Among authors: azibani f. Ann Intensive Care. 2024 Jun 14;14(1):89. doi: 10.1186/s13613-024-01325-y. Ann Intensive Care. 2024. PMID: 38877367 Free PMC article. Review.
Inhibition of circulating dipeptidyl-peptidase 3 by procizumab in experimental septic shock reduces catecholamine exposure and myocardial injury.
Garcia B, Ter Schiphorst B, Santos K, Su F, Dewachter L, Vasques-Nóvoa F, Rocha-Oliveira E, Roncon-Albuquerque R Jr, Uba T, Hartmann O, Picod A, Azibani F, Callebert J, Goldman S, Annoni F, Favory R, Vincent JL, Creteur J, Taccone FS, Mebazaa A, Herpain A. Garcia B, et al. Among authors: azibani f. Intensive Care Med Exp. 2024 Jun 7;12(1):53. doi: 10.1186/s40635-024-00638-3. Intensive Care Med Exp. 2024. PMID: 38849640 Free PMC article.
High Circulating Dipeptidyl Peptidase 3 Predicts Mortality and Need for Organ Support in Cardiogenic Shock: An Ancillary Analysis of the ACCOST-HH Trial.
Picod A, Nordin H, Jarczak D, Zeller T, Oddos C, Santos K, Hartmann O, Herpain A, Mebazaa A, Kluge S, Azibani F, Karakas M. Picod A, et al. Among authors: azibani f. J Card Fail. 2024 Apr 30:S1071-9164(24)00146-5. doi: 10.1016/j.cardfail.2024.03.014. Online ahead of print. J Card Fail. 2024. PMID: 38697465 Free article.
A Fab of trastuzumab to treat HER2 overexpressing breast cancer brain metastases.
Angeli E, Paris J, Le Tilly O, Desvignes C, Gapihan G, Boquet D, Pamoukdjian F, Hamdan D, Rigal M, Poirier F, Lutomski D, Azibani F, Mebazaa A, Herbet A, Mabondzo A, Falgarone G, Janin A, Paintaud G, Bousquet G. Angeli E, et al. Among authors: azibani f. Exp Hematol Oncol. 2024 Apr 15;13(1):41. doi: 10.1186/s40164-024-00513-7. Exp Hematol Oncol. 2024. PMID: 38622749 Free PMC article.
Long-Term Follow-up of Human Immunodeficiency Virus-Associated Pulmonary Hypertension: Clinical Features and Survival Outcomes of the Pan Africa Pulmonary Hypertension Cohort (PAPUCO).
Thienemann F, Katoto PDMC, Azibani F, Kodogo V, Mukasa SL, Sani MU, Karaye KM, Mbanze I, Mocumbi AO, Dzudie A, Sliwa K. Thienemann F, et al. Among authors: azibani f. Open Forum Infect Dis. 2022 Nov 28;9(12):ofac604. doi: 10.1093/ofid/ofac604. eCollection 2022 Dec. Open Forum Infect Dis. 2022. PMID: 36601555 Free PMC article.
Effects of enrichment strategies on outcome of adrecizumab treatment in septic shock: Post-hoc analyses of the phase II adrenomedullin and outcome in septic shock 2 trial.
van Lier D, Picod A, Marx G, Laterre PF, Hartmann O, Knothe C, Azibani F, Struck J, Santos K, Zimmerman J, Bergmann A, Mebazaa A, Pickkers P. van Lier D, et al. Among authors: azibani f. Front Med (Lausanne). 2022 Dec 1;9:1058235. doi: 10.3389/fmed.2022.1058235. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36530868 Free PMC article.
50 results